中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
17期
27-27,29
,共2页
肺心病%顽固性心力衰竭%治疗体会
肺心病%頑固性心力衰竭%治療體會
폐심병%완고성심력쇠갈%치료체회
Pulmonary heart disease%Intractable heart failure%Experience of treatment
目的：探讨肺心病伴顽固性心力衰竭的临床治疗体会。方法：2008年1月-2013年1月收治肺心病伴顽固性心力衰患者172例，回顾性分析临床治疗。在综合治疗基础上，分为两组分别加用培哚普利和酚妥拉明，探讨临床治疗效果，分析总结治疗效果和治疗体会。结果：甲组显效9例(10.5%)，总有效率55.8%；乙组显效8例(9.3%)，总有效率57.0%。结论：在治疗顽固性心力衰竭过程中，应用血管活性药物可提高治疗效果，另外，在治疗过程中应注意分析个体的伴发病情况，针对用药，可使疗效满意。
目的：探討肺心病伴頑固性心力衰竭的臨床治療體會。方法：2008年1月-2013年1月收治肺心病伴頑固性心力衰患者172例，迴顧性分析臨床治療。在綜閤治療基礎上，分為兩組分彆加用培哚普利和酚妥拉明，探討臨床治療效果，分析總結治療效果和治療體會。結果：甲組顯效9例(10.5%)，總有效率55.8%；乙組顯效8例(9.3%)，總有效率57.0%。結論：在治療頑固性心力衰竭過程中，應用血管活性藥物可提高治療效果，另外，在治療過程中應註意分析箇體的伴髮病情況，針對用藥，可使療效滿意。
목적：탐토폐심병반완고성심력쇠갈적림상치료체회。방법：2008년1월-2013년1월수치폐심병반완고성심력쇠환자172례，회고성분석림상치료。재종합치료기출상，분위량조분별가용배타보리화분타랍명，탐토림상치료효과，분석총결치료효과화치료체회。결과：갑조현효9례(10.5%)，총유효솔55.8%；을조현효8례(9.3%)，총유효솔57.0%。결론：재치료완고성심력쇠갈과정중，응용혈관활성약물가제고치료효과，령외，재치료과정중응주의분석개체적반발병정황，침대용약，가사료효만의。
Objective:To investigate the clinical experience in treating pulmonary heart disease with intractable heart failure. Methods:We retrospective analyzed the clinical treatment of 172 cases of pulmonary heart disease with intractable heart failure patients from January 2008 to January 2013.On the basis of the comprehensive treatment,we divided them into two groups were respectively treated with perindopril and phentolamine.We investigated the clinical effect of treatment, analyzed and summed up the curative effect and the experience of treatment.Results:9 cases were markedly effective in group A(10.5% ),and the total efficiency was 55.8% .8 cases were markedly effective in group B(9.3% ),and the total efficiency was 57% .Conclusion:In the treatment of intractable heart failure process,the vasoactive medications can improve the treatment effect,in addition,we should pay more attention to analyze the concomitant disease of individual in the course of treatment,and give the personalized medicine, so we can make the curative effect is satisfactory.
